NeuroSense Therapeutics Ltd.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $597.0K | $11.4M | $11.1M |
| FY2022 | $1.9M | $7.7M | $3.5M |
| FY2023 | $4.9M | $3.2M | $2.6M |
| FY2024 | $2.0M | $4.6M | $3.4M |
| FY2025 | $2.6M | $1.0M | $166.0K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $597.0K | $11.4M | $11.1M |
| FY2022 | $1.9M | $7.7M | $3.5M |
| FY2023 | $4.9M | $3.2M | $2.6M |
| FY2024 | $2.0M | $4.6M | $3.4M |
| FY2025 | $2.6M | $1.0M | $166.0K |